Can Lyme Disease Trigger Autoimmune Symptoms?

Lyme disease autoimmune symptoms are increasingly discussed as patients experience persistent or evolving symptoms even after treatment.

While Lyme disease is caused by infection, the body’s response to that infection may continue long after the initial trigger.

How Infections Can Trigger Autoimmune Responses

The immune system is designed to fight infections. But in some cases, that response can become misdirected.

Research has shown that infections—both bacterial and viral—can trigger autoimmune or inflammatory conditions through several mechanisms.

Molecular mimicry: Microbial proteins resemble human tissue, leading the immune system to attack both
Epitope spreading: Tissue damage exposes new antigens, expanding the immune response
Bystander activation: Inflammation activates immune cells in a non-specific way

These immune mechanisms have been described across multiple infectious diseases and provide a framework for understanding how infections such as Lyme disease may contribute to persistent or evolving symptoms through immune system activation.

What This Means in Lyme Disease

In Lyme disease, symptoms do not always follow a simple pattern of infection and recovery.

Some patients improve with treatment. Others continue to experience symptoms such as:

Fatigue
Brain fog
Nerve pain
Joint symptoms

These symptoms may reflect ongoing immune activation, persistent infection, untreated coinfections, or a combination of these factors.

In clinical practice, persistent symptoms are often multifactorial. In some patients, ongoing infection or coinfections such as Babesia or Bartonella may contribute to symptoms. In others, immune activation or inflammation may play a larger role. These processes are not mutually exclusive and may overlap.

This helps explain why Lyme disease can resemble autoimmune or neurologic conditions in some patients.

Why Symptoms May Persist After Treatment

One of the most important insights from immunology research is that symptoms can continue even after the infection is no longer detectable.

In some conditions, the immune response becomes self-sustaining, continuing to affect tissues and organ systems after the initial trigger has resolved.

In Lyme disease, this may contribute to what is described as
post-treatment Lyme disease syndrome (PTLDS).

Post-treatment Lyme disease syndrome (PTLDS) is a term used in research to describe patients who continue to experience symptoms after standard antibiotic therapy.

Importantly, PTLDS is a descriptive definition—it does not specify the underlying cause of symptoms. Ongoing research continues to explore whether these symptoms may reflect immune dysregulation, persistent infection, coinfections, or a combination of these factors.

This distinction allows clinicians to recognize persistent symptoms while remaining open to multiple biologic explanations, which may vary from patient to patient.

It also overlaps with findings in
neuroinflammation in Lyme disease, where immune activation affects the nervous system and contributes to cognitive and sensory symptoms.

At the same time, some patients may have ongoing infection or coinfections that continue to drive symptoms, further complicating the clinical picture.

A More Nuanced View of Lyme Disease

Lyme disease is not simply an infection—it is an interaction between the infection and the immune system.

For some patients, the immune response resolves cleanly.

For others, symptoms may be driven by a combination of persistent infection, immune dysregulation, and inflammation.

This does not mean Lyme disease is purely autoimmune. But it does mean that immune mechanisms—and their interaction with infection—may play an important role in persistent symptoms.